Insider Transactions in Q2 2023 at Bio Xcel Therapeutics, Inc. (BTAI)
Insider Transaction List (Q2 2023)
Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
---|---|---|---|---|---|
Jun 16
2023
|
Vimal Mehta CEO and President |
SELL
Open market or private sale
|
Direct |
30,000
-15.69%
|
$600,000
$20.93 P/Share
|
Jun 16
2023
|
Vimal Mehta CEO and President |
BUY
Exercise of conversion of derivative security
|
Direct |
30,000
+30.03%
|
$0
$0.41 P/Share
|
Jun 15
2023
|
Vimal Mehta CEO and President |
SELL
Open market or private sale
|
Direct |
30,000
-24.09%
|
$630,000
$21.66 P/Share
|
Jun 15
2023
|
Vimal Mehta CEO and President |
BUY
Exercise of conversion of derivative security
|
Direct |
30,000
+30.03%
|
$0
$0.41 P/Share
|
Jun 14
2023
|
Frank Yocca Chief Scientific Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
521
+4.94%
|
-
|
Jun 14
2023
|
Javier Rodriguez Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
521
+9.66%
|
-
|
Jun 14
2023
|
Vimal Mehta CEO and President |
BUY
Exercise of conversion of derivative security
|
Direct |
2,609
+6.14%
|
-
|
Jun 14
2023
|
Richard I Steinhart Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
521
+20.5%
|
-
|
Jun 14
2023
|
Vincent O'Neill Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
521
+22.84%
|
-
|
May 22
2023
|
Vimal Mehta CEO and President |
SELL
Open market or private sale
|
Direct |
6,500
-14.84%
|
$162,500
$25.79 P/Share
|
May 15
2023
|
Javier Rodriguez Officer |
SELL
Open market or private sale
|
Direct |
1,785
-29.1%
|
$48,195
$27.32 P/Share
|
May 15
2023
|
Richard I Steinhart Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
5,000
-76.92%
|
$135,000
$27.17 P/Share
|
May 14
2023
|
Javier Rodriguez Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
5,000
+44.9%
|
-
|
May 14
2023
|
Richard I Steinhart Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
5,000
+43.48%
|
-
|
May 14
2023
|
Vimal Mehta CEO and President |
BUY
Exercise of conversion of derivative security
|
Direct |
15,000
+32.68%
|
-
|
Apr 06
2023
|
Krishnan Nandabalan Director |
SELL
Open market or private sale
|
Direct |
60,000
-100.0%
|
$1,020,000
$17.32 P/Share
|
Apr 06
2023
|
Krishnan Nandabalan Director |
BUY
Exercise of conversion of derivative security
|
Direct |
60,000
+50.0%
|
$0
$0.41 P/Share
|